Persist AI has launched the 'Micromill' platform in collaboration with Microsize and Micromacinazione to enhance early-stage drug formulation decision-making.
Jun 03, 2026
West SacramentoManufacturingBiotechnologyHealth CareArtificial IntelligencePharmaceutical
Product Description
The 'Micromill' platform provides an integrated formulation workflow using just milligrams of API, allowing formulation teams to make informed decisions early in the drug development process.
Company Information
Company
Persist AI
Location
890 Embarcadero Dr.
West Sacramento, California, United States
About
Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023.
Fundz sees it the moment Persist AI ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
West SacramentoManufacturingBiotechnologyHealth CareArtificial IntelligencePharmaceutical